Koentjoro et al. showed that in patients with PD caused by PINK1/Parkin pathway disruption, NIX acts as a neuroprotective agent, rescuing mitophagy and increasing neuronal cell and fibroblast viability (Koentjoro et al., 2017). This evidence concerns the gene PRKN and Parkinson disease.